Clinical Trials in Massachusetts

Showing 9801-9820 of 13,570 trials

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

NCT00451321

The purpose of this study is to optimize several multi-dose regimens of otelixizumab, determine the highest biologically active dose, evaluate biomarkers and surrogates of efficacy, and to evaluate the effects of each multi-dose regimen of otelixizumab against standard safety and efficacy parameters.

Diabetes Mellitus, Type 1

GlaxoSmithKline88 participantsStarted Jul 2006

Birmingham, Alabama, United States • Walnut Creek, California, United States • Aurora, Colorado, United States +14 more locations

COMPLETEDNA26 miles

Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas

NCT01161862

The investigators hypothesize that our closed-loop glucose-control system can provide BG control in subjects with type 1 diabetes using the estimated BG signal from a CGM as the input signal to the controller.

Diabetes Mellitus

Boston University Charles River Campus24 participantsStarted Jul 2010

Boston, Massachusetts, United States

TRX4 Monoclonal Antibody in Type 1 Diabetes (T1 DM)

Integration of Continuous Glucose Monitoring Into a BiHormonal Closed-Loop Artificial Pancreas

Find Trials by Condition in Massachusetts

Ninvasive Cardiac Output Measurements During Cesarean Delivery Under Spinal Anesthesia.

Improving Functional Capacity in Fontan Patients Through Inspiratory Muscle Training

Extended Follow-Up After Islet Transplantation in T1D

A Study to Evaluate the Safety and Tolerability of Valproic Acid in Trauma Patients(Part 2)

S0601 Rituximab, Combination Chemotherapy, and Bortezomib Followed by Bortezomib Alone in Treating Patients With Newly Diagnosed Mantle Cell Lymphoma

A Dose-Finding Study of GSK2894512 Cream in Subjects With Plaque Psoriasis

A Clinical Trial Testing The Efficacy Of Crizotinib Versus Standard Chemotherapy Pemetrexed Plus Cisplatin Or Carboplatin In Patients With ALK Positive Non Squamous Cancer Of The Lung

Minimally Invasive Closure of Umbilical Hernias

Fluticasone Propionate/Salmeterol Combination 250/50 DISKUS in the Exercise Endurance Time in Patients With Chronic Obstructive Pulmonary Disease

VEG111485: A QTc Study of Pazopanib

Single Dose Intravesical Apaziquone Postoperative in Patients Undergoing TURBT for Noninvasive Bladder Cancer (SPI-612)

Pharmacokinetics And Pharmacodynamics Of Lapatinib In Two Dosing Regimens In Treatment-naive Patients With Breast Cancer

Evaluating the Efficacy and Safety of Fluticasone Furoate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents

Study to Evaluate the 24-Hour Pulmonary Function Profile of Fluticasone Furoate (FF) /GW642444 (Vilanterol) (VI) Inhalation Powder 100/25mcg Once Daily Compared With Fluticasone Propionate/Salmeterol Inhalation Powder 250/50mcg Twice Daily in Subjects With Chronic Obstructive Pulmonary Disease

A Pharmacokinetics Study of the Effects of GSK2118436 on Warfarin, the Effects of Ketoconazole and Gemfibrozil on GSK2118436, and the Effects of Repeat Doses of GSK2118436 in Subjects With BRAF Mutant Solid Tumors

A Phase IIIb Study to Evaluate the Efficacy of Umeclidinium/Vilanterol (UMEC/VI) in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

A Study of the GSK MEK Inhibitor GSK1120212 and Everolimus in Cancer Subjects

Fractional Flow Reserve Versus Angiography for Multivessel Evaluation (F.A.M.E.)